Percutaneous radiofrequency ablation for liver tumors: Is it safer and more effective in low-risk areas than in high-risk areas?

Hepatology Research

Volumn 41, Issue 7, 2011, Pages 635-640

  Tang, Zhe ^a   Fang, Heqing ^a   Kang, Muxing ^a   Zhang, Bo ^a   Dong, Xin ^a   Chen, Xiangming ^a   Xu, Jun ^a   Chen, Jianke ^a   Wu, Yulian ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Complication; Liver cancer; Radiofrequency ablation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BILE LEAKAGE; BLEEDING; DIAPHRAGM; FEASIBILITY STUDY; FEMALE; FEVER; GALLBLADDER; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TUMOR; LUNG HILUS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS RADIOFREQUENCY ABLATION; POSTOPERATIVE PAIN; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SAFETY; VEIN THROMBOSIS;

EID: 79959800989     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00817.x     Document Type: Article

References (17)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
2. Scheele J, Stang R, Altendorf A etal. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
3. Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2004; 5: 268-76.
4. De Baere T, Risse O, Kuoch V etal. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol 2003; 181: 695-700.
5. Peng ZW, Liang HH, Chen MS etal. Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe. Eur J Surg Oncol 2008; 34: 166-72.
6. Sartori S, Tombesi P, Macario F etal. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology 2008; 248: 670-9.
7. National Cancer Institute. Cancer therapy evaluation program: common toxicity evaluation manual, version 2.0, June 1, 1999. [Cited 15 Dec 2004.] Available from URL.
8. Goldberg SN, Grassi CJ, Cardella JF etal. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235: 728-39.
9. Tanabe KK, Curley SA, Dodd GD etal. Radiofrequency ablation. The experts weigh in. Cancer 2003; 100: 641-50.
10. Garrean S, Hering J, Saied A etal. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 2008; 195: 508-20.
11. Lencioni R, Cioni D, Crocetti L etal. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-7.
12. Tateishi R, Shiina S, Teratani T etal. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-9.
13. Meloni MF, Livraghi T, Filice C etal. Radiofrequency ablation of liver tumors: the role of microbubble ultrasound contrast agents. Ultrasound Q 2006; 22: 41-7.
14. Bilchik AJ, Wood TF, Allegra D etal. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg 2000; 135: 657-62.
15. Rossi S, DiStasi M, Buscarini E etal. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 1996; 167: 759-68.
16. Patti JW, Neeman Z, Wood BJ. Radiofrequency ablation treatment in proximity to the gallbladder without subsequent acute cholecystitis. Cardiovasc Intervent Radiol 2003; 26: 413-5.
17. Bonny C, Abergel A, Gayard P etal. Radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis. Gastroenterol Clin Biol 2002; 26: 735-41.